@FiercePharma: Now out: This week's issue of FierceVaccines. Weekly report | Follow @FiercePharma
@TracyStaton: Trending now at FiercePharma: Novo Nordisk lays out plans to recruit 6,000 workers in R&D, production. Story | Follow @TracyStaton
@EricPFierce: How much are the big dogs of Big Pharma paid? A lot. See the top 15 highest paid CEOs here. | Follow @EricPFierce
@CarlyHFierce: Czech scientists have a Lyme disease vaccine ready for animal use. A few of my favorite things in here, and Lyme disease isn't one of them. Story | Follow @CarlyHFierce
> India's Cipla teamed up with Hetero to launch a biosimilar version of Amgen's ($AMGN) anemia treatment Aranesp in its home country. Release | Report
> A Delaware judge found that generics maker Watson Laboratories, now owned by Actavis ($ACT), stepped on Novartis' ($NVS) patents for the Alzheimer's treatment patch Exelon. Release | Report
> U.S.-based Mylan ($MYL) pulled batches of an injectable antibiotic, made in Poland for sale under the Agila brand, because of possible impurities. Report
> The U.K.'s cost-effectiveness agency will hold an oral appeal hearing for the prostate cancer treatment Firmagon, which was approved in April, but for a limited patient group. Release
> The Indian generics maker Dr. Reddy's pulled more than 13,000 bottles of its copy of AstraZeneca's ($AZN) blood pressure treatment Toprol XL. Report
Medical Device News
@FierceMedDev: EnteroMedics up in early trading after mixed FDA panel vote. More | Follow @FierceMedDev
@StacyALawrence: Medtronic merger could give Covidien execs an $80M payout. Story | Follow @StacyALawrence
@MichaelGFierce: UPenn team combats Parkinson's with immunotherapy that targets neuron killers. Story from FierceBiotechResearch | Follow @MichaelGFierce
@EmilyWFierce: Single gene mutations that lower triglyceride levels could spur the development of a new class of heart disease drugs. Article | Follow @EmilyWFierce
> Data: Medtronic personalized defibrillator safer, cheaper. More
> Covidien endovascular unit could be target for cuts after Medtronic merger. Story
> Covidien recalls potentially faulty Hydrofinity guidewire. Article
Biotech News
@FierceBiotech: Navitor grabs a $23.5M A round to tackle a key crossroad for disease. More | Follow @FierceBiotech
@JohnCFierce: Man, that Burrill lawsuit makes for interesting reading. Story | Follow @JohnCFierce
@DamianFierce: J&J Innovation's summer class of biotechs targets obesity, insomnia, heart failure, cancer and more. News | Follow @DamianFierce
> Zafgen, Ardelyx bank $156M in IPOs, recalling biotech's winter boom. More
> J&J pays $30M to grab rights to Vertex program. Item
> Takeda dumps its top cancer contender after a late-stage struggle. Story
Vaccines News
> Merck, Sanofi JV wins anal cancer indication for Gardasil in EU. Story
> Themis Chikungunya prophylactic hits Phase I goal. More
> Pfizer puts the heat on Novartis with FDA MenB filing. Article
> Novartis submits Bexsero to FDA in race for MenB market. News
> MenB survivors call for Bexsero coverage in Australia. Item
> Novartis facility grabs FDA license to produce cell-culture vaccines. Report
Pharma Manufacturing News
> EMA GMP inspectors working group making updates for this year. Item
> Ranbaxy's FDA problems stymie launch of generic Nexium and the relief it would bring to consumers. More
> Dr. Reddy's initiates 2 recalls even as it invests to remove human error. Story
> Grifols doubles capacity with new U.S. plasma fractionation plant. Article
> Counterfeit antibiotics feed drug resistance, superbugs. News
> FDA finds fault with Chinese API maker. Report
And Finally... Americans slept more last year, but worked less, thanks to a groggy economy. Report